New era begins at Merck as pandemic cuts Q1 sales, profit By LINDA A. JOHNSON - Associated Press Shares
U.S. health panel urges restarting Johnson & Johnson COVID-19 vaccinations By Shen Wu Tan - The Washington Times Shares
US to resume J&J COVID vaccinations despite rare clot risk By LAURAN NEERGAARD and MIKE STOBBE - Associated Press Shares
European regulator finds “possible link” between Johnson & Johnson’s vaccine and very rare blood clo Associated Press Shares
Biden celebrates widespread vaccine eligibility: ‘You need to be protected’ By Tom Howell Jr. - The Washington Times Shares
COVID-19 cases rising despite half of adults in U.S. receiving their first vaccine By Tom Howell Jr. - The Washington Times Shares
J&J vaccine to remain in limbo while officials seek evidence By LAURAN NEERGAARD and MIKE STOBBE - Associated Press Shares
